Vestibulotoxicity with systemic gentamicin in different dosing regimens: Our experience in 46 patients.

Syed, M I; Leis, J A; Ilan, O; Gold, W L; Pothier, D D; Rutka, J A

Syed, M I; Leis, J A; Ilan, O; Gold, W L; Pothier, D D; Rutka, J A.

Affiliation

Syed MI; Otolaryngology, The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Leis JA; Division of Infectious Diseases, Department of Medicine, University of Toronto & Centre for Quality Improvement and Patient Safety, University of Toronto, Toronto, ON, Canada.
Ilan O; Otology/Neurotology, University Health Network, Toronto, ON, Canada.
Gold WL; Toronto General Research Institute, University Health Network, Toronto, ON, Canada.
Pothier DD; Otology/Neurotology, University Health Network, Toronto, ON, Canada.
Rutka JA; Otology/Neurotology, University Health Network, Toronto, ON, Canada.

Clin Otolaryngol ; 42(5): 1091-1095, 2017 10.

Article de En | MEDLINE | ID: mdl-28296174

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Gentamicine / Maladies vestibulaires / Antibactériens Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Clin Otolaryngol Sujet du journal: OTORRINOLARINGOLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google